Worldnews

Pfizer/BioNTech says three doses ‘effective’ against Omicron-


By AFP

FRANKFURT: The coronavirus vaccine developed jointly by BioNTech and Pfizer is “still effective” against the Omicron variant of the virus after three doses, the German company said in a statement on Wednesday.

An Omicron-specific version of the jab, currently in development by BioNTech, would be available “by March”, it added.



Source link

You Missed

Top StoriesMay 15, 2026

Buying of Sunflower to Resume Soon

Karimnagar: MARKFED district manager Mohmaad Habeeb on Thursday said the government was committed to procuring the entire sunflower…

Scroll to Top